Clinical Trial

Investigating the Safety and Efficacy of the 1927-nm Thulium Laser in Keratosis Pilaris

Study acronym: KP
Recruiting
View on ClinicalTrials.gov →
Summary
Keratosis pilaris (KP) is a very common skin condition that affects up to 80% of adolescents and 40% of adults. Clinically, KP causes rough dry patches and tiny spiny bumps around the hair follicles, as well as redness and pigmentation changes, most often on the upper arms, thighs, cheeks, or buttocks. While KP is benign, it can be cosmetically very bothersome. Currently, treatment options for KP are limited, and consist of topical moisturizers and keratolytic agents, but often leads to suboptimal improvements. In literature, many laser treatment modalities for KP have been studied, with varying results. The primary aim of this pilot study is to investigate how KP, a predominantly follicular disorder, responds to treatment with the 1927-nm Thulium laser.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-21; most recent amendment 2025-11-24.
Trial Details
NCT Number NCT07078461
Lead Sponsor Johns Hopkins University
Conditions Keratosis Pilaris (KP)
Enrollment 25 participants
Start Date 2025-10-23
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-11-26